Ireland
--:--IST
Recruiting Not applicable

Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience

NCT06905119 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2023-05-04
Last updated
2025-09-12

Condition(s) studied

Infusions, IntravenousAdministration, IntravenousHome Infusion TherapyParenteral Nutrition, HomeCentral Venous CathetersCatheterization, Central VenousCatheterization, PeripheralVascular Access DevicesPatient Education as TopicPatient ParticipationUser-Computer InterfaceSmartphoneMobile ApplicationsComputers, HandheldDigital HealthNursingCare GiversDelivery of Health CareHome NursingSelf AdministrationAdverse EffectsCatheter-Related InfectionsTelemedicine

Investigational drug(s) / intervention(s)

Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters

Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: The application is offered to all patients at the time of PICC placement. If they accept, they go to the intervention group. If they do not accept, they go to the control group.

Study summary

The study focuses on patients who require outpatient infusion of therapy ("Infusions, Intravenous"\[Mesh\]) "Administration, Intravenous"\[Mesh\] ("Home Infusion Therapy"\[Mesh\]) "Parenteral Nutrition, Home"\[Mesh\] via a peripherally inserted central catheter (PICC) ("Central Venous Catheters"\[MeSH\] "Catheterization, Central Venous"\[MeSH\] "Catheterization, Peripheral" \[MeSH\] "Vascular Access Devices"\[Mesh\] )

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients \>18 years. * Sign the informed consent form. * Have a Smartphone and accept the use of the APP. * Patient with a PICC inserted by the Infusion and Vascular Access Team of the University Hospital of Navarra and with a planned use of at least one month. Exclusion Criteria: * Patients with limitations in the use of digital resources or lack of Smartphone. * Patients who do not want to install the APP on their Smartphone * Patients who do not authorize access to their Computerized Medical Record (HCI).

Primary outcome measure(s)

  • 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC — At the end of intervention: Time from PICC placement to removal.
    Number of phlebitis episodes
  • 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC. — At the end of intervention: Time from PICC placement to removal.
    Number of episodes of catheter removal by reason for removal: pain
  • 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC. — At the end of intervention: Time from PICC placement to removal.
    Number of infection episodes
  • 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC. — At the end of the intervention: Time from PICC placement to removal.
    Number of episodes of withdrawal reason due to accidental exit
  • 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC. — At the end of intervention: Time from PICC placement to removal.
    Number of episodes of skin lesions
  • 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC. — At the end of intervention: Time from PICC placement to removal.
    Number of thrombosis episodes
  • 1. Patients who use computerized applications are more involved in their care and have fewer complications with the PICC. — At the end of intervention: Time from PICC placement to removal.
    Number of episodes of catheter breakage as a reason for removal

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario de Navarra Pamplona Navarre Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06905119 on ClinicalTrials.gov ↗ ← All trials in Spain